On September 19, 2022, Pediatrix Medical Group, Inc. announced that Dominic J. Andreano, the Company's Executive Vice President, General Counsel and Secretary, would transition from such position, effective on or about October 14, 2022. Mr. Andreano's transition from his role as Executive Vice President, General Counsel and Secretary of the Company is a termination without “Cause” pursuant to that certain Amended and Restated Employment Agreement, effective September 27, 2020, by and between Mr. Andreano and a wholly-owned subsidiary of the Company, and Mr. Andreano will receive the benefits thereunder following the execution of a general release of claims in favor of the Company. The Company and Mr. Andreano intend to enter into a consulting agreement pursuant to which Mr. Andreano will continue to serve as an advisor to the Company following the Effective Date.

Ms. Mary Ann Moore, the Company's Executive Vice President, Chief Enterprise Risk and Legal Operations Officer, will be appointed the Company's Executive Vice President, General Counsel and Secretary upon Mr. Andreano's transition from his current role.